Literature DB >> 16932857

Macrochanneled poly (epsilon-caprolactone)/ hydroxyapatite scaffold by combination of bi-axial machining and lamination.

Young-Hag Koh1, Chang-Jun Bae, Jong-Jae Sun, In-Kook Jun, Hyoun-Ee Kim.   

Abstract

A combination of bi-axial machining and lamination was used to fabricate macrochanneled poly (epsilon-caprolactone) (PCL)/hydroxyapatite (HA) scaffolds. Thermoplastic PCL/HA sheets with a thickness of 1 mm, consisting of a 40 wt% PCL polymer and 60 wt% HA particles, were bi-axially machined. The thermoplastic PCL/HA exhibited an excellent surface finish with negligible tearing of the PCL polymer and pull-out of the HA particles. The bi-axially machined sheets were laminated with a solvent to give permanent bonding between the lamina. This novel process produced three-directionally connected macrochannels in the dense PCL/HA body. The macrochanneled PCL/HA scaffold exhibited excellent ductility and reasonably high strength. In addition, good cellular responses were observed due to the osteoconductive HA particles.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16932857     DOI: 10.1007/s10856-006-9834-1

Source DB:  PubMed          Journal:  J Mater Sci Mater Med        ISSN: 0957-4530            Impact factor:   3.896


  12 in total

1.  Scaffolds in tissue engineering bone and cartilage.

Authors:  D W Hutmacher
Journal:  Biomaterials       Date:  2000-12       Impact factor: 12.479

2.  Mechanical and in vivo performance of hydroxyapatite implants with controlled architectures.

Authors:  T M Gabriel Chu; David G Orton; Scott J Hollister; Stephen E Feinberg; John W Halloran
Journal:  Biomaterials       Date:  2002-03       Impact factor: 12.479

3.  Fused deposition modeling of novel scaffold architectures for tissue engineering applications.

Authors:  Iwan Zein; Dietmar W Hutmacher; Kim Cheng Tan; Swee Hin Teoh
Journal:  Biomaterials       Date:  2002-02       Impact factor: 12.479

4.  Bioresorbable devices made of forged composites of hydroxyapatite (HA) particles and poly-L-lactide (PLLA): Part I. Basic characteristics.

Authors:  Y Shikinami; M Okuno
Journal:  Biomaterials       Date:  1999-05       Impact factor: 12.479

5.  Hydroxyapatite fiber reinforced poly(alpha-hydroxy ester) foams for bone regeneration.

Authors:  R C Thomson; M J Yaszemski; J M Powers; A G Mikos
Journal:  Biomaterials       Date:  1998-11       Impact factor: 12.479

6.  Structural and material mechanical properties of human vertebral cancellous bone.

Authors:  P H Nicholson; X G Cheng; G Lowet; S Boonen; M W Davie; J Dequeker; G Van der Perre
Journal:  Med Eng Phys       Date:  1997-12       Impact factor: 2.242

7.  Mechanisms of polymer degradation in implantable devices. I. Poly(caprolactone).

Authors:  S A Ali; S P Zhong; P J Doherty; D F Williams
Journal:  Biomaterials       Date:  1993-07       Impact factor: 12.479

8.  Development and properties of polycaprolactone/hydroxyapatite composite biomaterials.

Authors:  M C Azevedo; R L Reis; M B Claase; D W Grijpma; J Feijen
Journal:  J Mater Sci Mater Med       Date:  2003-02       Impact factor: 3.896

9.  Osteoblast growth and function in porous poly epsilon -caprolactone matrices for bone repair: a preliminary study.

Authors:  G Ciapetti; L Ambrosio; L Savarino; D Granchi; E Cenni; N Baldini; S Pagani; S Guizzardi; F Causa; A Giunti
Journal:  Biomaterials       Date:  2003-09       Impact factor: 12.479

10.  Design of porous scaffolds for cartilage tissue engineering using a three-dimensional fiber-deposition technique.

Authors:  T B F Woodfield; J Malda; J de Wijn; F Péters; J Riesle; C A van Blitterswijk
Journal:  Biomaterials       Date:  2004-08       Impact factor: 12.479

View more
  1 in total

1.  A 3D Printed Composite Scaffold Loaded with Clodronate to Regenerate Osteoporotic Bone: In Vitro Characterization.

Authors:  Stefania Cometa; Maria Addolorata Bonifacio; Elisabetta Tranquillo; Antonio Gloria; Marco Domingos; Elvira De Giglio
Journal:  Polymers (Basel)       Date:  2021-01-01       Impact factor: 4.329

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.